U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H22O3
Molecular Weight 286.3655
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 4-HYDROXYESTRONE

SMILES

[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]3([H])C4=C(CC[C@@]23[H])C(O)=C(O)C=C4

InChI

InChIKey=XQZVQQZZOVBNLU-QDTBLXIISA-N
InChI=1S/C18H22O3/c1-18-9-8-11-10-4-6-15(19)17(21)13(10)3-2-12(11)14(18)5-7-16(18)20/h4,6,11-12,14,19,21H,2-3,5,7-9H2,1H3/t11-,12-,14+,18+/m1/s1

HIDE SMILES / InChI

Molecular Formula C18H22O3
Molecular Weight 286.3655
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/11054642

4-Hydroxyestrone (4-OHE1) is a carcinogenic metabolite originating from 17beta-estradiol (17β-E2) hormone. 4-OHE1 was a partial estrogen agonist on cancellous bone turnover, similar to 17β-E2, is able to emit electrons from its excited singlet state. The quantum yield is nearly the same like this of 17β-E2 and decreases with increasing substrate concentration, but enhances with temperature. The 4-OHE1 transient derived from the electron ejection process is leading to the formation of a secondary metabolite by reaction with the present C2H4OH radical. This fact indicates, that depending on the life habits of a person, a variety of metabolites can be formed, also such initiating cancer.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Reinduction of the hypnotic effects of thiopental with NSAIDs by decreasing thiopental plasma protein binding in humans.
1993 Apr
Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs.
1993 Jan
cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily.
1993 Jul 15
Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.
1994 Sep-Oct
Characterization of rabbit UDP-glucuronosyltransferase UGT1A7: tertiary amine glucuronidation is catalyzed by UGT1A7 and UGT1A4.
1997 Aug 15
Involvement of genotoxic effects in the initiation of estrogen-induced cellular transformation: studies using Syrian hamster embryo cells treated with 17beta-estradiol and eight of its metabolites.
2000 Apr 1
Quantitative determination of 3,3'-diindolylmethane in urine of individuals receiving indole-3-carbinol.
2001
Selective synthesis of 4-methoxyestrogen from 4-hydroxyestrogen.
2001 Aug
Equine estrogen metabolite 4-hydroxyequilenin induces DNA damage in the rat mammary tissues: formation of single-strand breaks, apurinic sites, stable adducts, and oxidized bases.
2001 Dec
Evidence that a metabolite of equine estrogens, 4-hydroxyequilenin, induces cellular transformation in vitro.
2001 Jan
In vitro generation of peroxynitrite by 2- and 4-hydroxyestrogens in the presence of nitric oxide.
2001 May
The ability of four catechol estrogens of 17beta-estradiol and estrone to induce DNA adducts in Syrian hamster embryo fibroblasts.
2001 Sep
Expression of UGT2B7, a UDP-glucuronosyltransferase implicated in the metabolism of 4-hydroxyestrone and all-trans retinoic acid, in normal human breast parenchyma and in invasive and in situ breast cancers.
2002 Apr
Catecholestrogen sulfation: possible role in carcinogenesis.
2002 Mar 29
Estradiol metabolism and malignant disease.
2002 Sep 30
Endogenous estradiol metabolites stimulate the in vitro proliferation of human osteoblastic cells.
2003 Apr
Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms.
2003 Aug
Spectroscopic characterization of the 4-hydroxy catechol estrogen quinones-derived GSH and N-acetylated Cys conjugates.
2003 Mar
Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry.
2003 May
Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract.
2003 Sep
Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation.
2004 Jul 2
Identification of UGT2B9*2 and UGT2B33 isolated from female rhesus monkey liver.
2004 Jun 1
Equine estrogen metabolite 4-hydroxyequilenin induces anchorage-independent growth of human mammary epithelial MCF-10A cells: differential gene expression.
2004 Jun 4
Effects of dioxin on metabolism of estrogens in waste incinerator workers.
2005 Jul-Aug
Development of monoclonal antibodies to 4-hydroxyestrogen-2-N-acetylcysteine conjugates: immunoaffinity and spectroscopic studies.
2005 Oct
Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone.
2006 Jan 1
Role of polymorphic human cytochrome P450 enzymes in estrone oxidation.
2006 Mar
Analysis of fifteen estrogen metabolites using packed column supercritical fluid chromatography-mass spectrometry.
2006 Mar 1
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods.
2006 Nov
Potential biomarker for early risk assessment of prostate cancer.
2006 Oct 1
Effects of a catechol-O-methyltransferase inhibitor on catechol estrogen-induced cellular transformation, chromosome aberrations and apoptosis in Syrian hamster embryo cells.
2007 Apr 15
Evaluation of electrospray ionization and atmospheric pressure chemical ionization for simultaneous detection of estrone and its metabolites using high-performance liquid chromatography/tandem mass spectrometry.
2007 Dec 1
In vitro short-term test evaluation of catecholestrogens genotoxicity.
2007 Jun-Jul
Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33.
2007 Mar
HPLC for stress-free screening of potential prostate cancer marker catechol estrogens in urine using a diamond-electrode electrochemical and a fluorescence detector.
2007 Sep
Contribution of alpha2-adrenoceptors to the mitogenic effect of catecholestrogen in human breast cancer MCF-7 cells.
2008 May
Hydroxylated estrogen metabolites influence the proliferation of cultured human monocytes: possible role in synovial tissue hyperplasia.
2008 Sep-Oct
Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women.
2009
Simultaneous determination of eight estrogens and their metabolites in serum using liquid chromatography with electrochemical detection.
2010 Apr 15
Redox cycling of catechol estrogens generating apurinic/apyrimidinic sites and 8-oxo-deoxyguanosine via reactive oxygen species differentiates equine and human estrogens.
2010 Aug 16
Comparison of estrogens and estrogen metabolites in human breast tissue and urine.
2010 Aug 2
Effects of a breast-health herbal formula supplement on estrogen metabolism in pre- and post-menopausal women not taking hormonal contraceptives or supplements: a randomized controlled trial.
2010 Dec 16
The 4-hydroxyestrone: Electron emission, formation of secondary metabolites and mechanisms of carcinogenesis.
2010 Jan 21
Degradation of natural estrogen and identification of the metabolites produced by soil isolates of Rhodococcus sp. and Sphingomonas sp.
2010 Jun
The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo.
2010 May 21
NRF2/long noncoding RNA ROR signaling regulates mammary stem cell expansion and protects against estrogen genotoxicity.
2014 Nov 7

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:01:20 GMT 2023
Edited
by admin
on Fri Dec 15 15:01:20 GMT 2023
Record UNII
3MN57C55S2
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
4-HYDROXYESTRONE
Common Name English
3,4-DIHYDROXY-1,3,5(10)-ESTRATRIEN-17-ONE
Systematic Name English
ESTRA-1,3,5(10)-TRIEN-17-ONE, 3,4-DIHYDROXY-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C2181
Created by admin on Fri Dec 15 15:01:20 GMT 2023 , Edited by admin on Fri Dec 15 15:01:20 GMT 2023
Code System Code Type Description
WIKIPEDIA
4-Hydroxyestrone
Created by admin on Fri Dec 15 15:01:20 GMT 2023 , Edited by admin on Fri Dec 15 15:01:20 GMT 2023
PRIMARY
NCI_THESAURUS
C114469
Created by admin on Fri Dec 15 15:01:20 GMT 2023 , Edited by admin on Fri Dec 15 15:01:20 GMT 2023
PRIMARY
FDA UNII
3MN57C55S2
Created by admin on Fri Dec 15 15:01:20 GMT 2023 , Edited by admin on Fri Dec 15 15:01:20 GMT 2023
PRIMARY
PUBCHEM
9971251
Created by admin on Fri Dec 15 15:01:20 GMT 2023 , Edited by admin on Fri Dec 15 15:01:20 GMT 2023
PRIMARY
MESH
C026418
Created by admin on Fri Dec 15 15:01:20 GMT 2023 , Edited by admin on Fri Dec 15 15:01:20 GMT 2023
PRIMARY
CAS
3131-23-5
Created by admin on Fri Dec 15 15:01:20 GMT 2023 , Edited by admin on Fri Dec 15 15:01:20 GMT 2023
PRIMARY
EPA CompTox
DTXSID00904312
Created by admin on Fri Dec 15 15:01:20 GMT 2023 , Edited by admin on Fri Dec 15 15:01:20 GMT 2023
PRIMARY
CHEBI
87602
Created by admin on Fri Dec 15 15:01:20 GMT 2023 , Edited by admin on Fri Dec 15 15:01:20 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY